Uncover key drivers, emerging technologies, and competitive movements shaping the veterinary active pharmaceutical ingredients manufacturing market from 2025–2034 with trusted insights from The Business Research Company
What Is The Base Market Size For The Veterinary Active Pharmaceutical Ingredients Manufacturing Market Today And What Will It Reach By 2029?
The market for veterinary active pharmaceutical ingredients production has experienced robust expansion over the past few years, projected to increase from its 2024 valuation of $7.46 billion to reach $8.03 billion by 2025, reflecting a compound annual growth rate of 7.7 percent, with this historical upward trajectory being fueled by factors such as the increasing number of pets, tighter regulatory requirements, greater emphasis placed on animal dietary needs, financial commitments to research and development endeavors, and overall worldwide economic progress.
Anticipation is high for substantial expansion within the veterinary active pharmaceutical ingredients production sector over the coming years, projecting a market valuation of $11.12 billion by 2029, driven by an 8.5% compound annual growth rate; this upward trajectory is fueled by several factors including progress in tailored veterinary treatments, the worldwide spread and deepening of the market, heightened attention to adhering to regulations, increasing emphasis placed on the well-being of animals, enhancements in how drugs are administered, and a stronger consumer pull for nutritional supplements, while key developments shaping this period involve technological leaps in production methods, a greater reliance on third parties for API production, a move toward APIs derived from biotechnology, the incorporation of digital tools and automated systems into manufacturing, and the worldwide integration of the veterinary API sphere.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7942&type=smp
What Factors Are Boosting The Veterinary Active Pharmaceutical Ingredients Manufacturing Market?
The anticipated expansion in the veterinary active pharmaceutical ingredients manufacturing sector is primarily fueled by the rising count of individuals acquiring companion animals. These proprietors are responsible for ensuring their animal companions receive appropriate medical provisions, consequently boosting the need for veterinary pharmaceuticals. A compelling illustration of this trend is observed in Australia, where, based on 2022 figures released by Animal Medicines Australia, a non-governmental entity situated there, pet ownership experienced substantial growth; the figure for pet owners climbed to 28,730.8 in that year, an escalation from the 39% recorded in 2021, marking a 24% rise, which distinctly signals a robust upward trajectory in the adoption and subsequent investment in animal welfare. This significant upturn in pet possession emphasizes the mounting prevalence of pets within Australian residences, inherently pushing the demand for the production of veterinary active pharmaceutical ingredients.
How Is The Veterinary Active Pharmaceutical Ingredients Manufacturing Market Categorized By Application, Type, And Region?
The veterinary active pharmaceutical ingredients manufacturing market covered in this report is segmented –
1) By Product: Antiparasitic, Anti-Infectives, Vaccines, NSAIDs
2) By Service Type: In House, Contract Outsourcing
3) By Synthesis Type: Chemical Based API, Biological API, Highly Potent API
Subsegments:
1) By Antiparasitic: Endectocides, Anthelmintics, Antiprotozoals
2) By Anti-Infectives: Antibiotics, Antifungals, Antivirals
3) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines
4) By NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Non-Selective NSAIDs, COX-2 Inhibitors
How Are Technological Trends Affecting The Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth?
A significant movement within the manufacturing sector for veterinary active pharmaceutical ingredients involves a growing emphasis on developing novel products, causing this trend to gain traction. Leading entities involved in this market are channeling efforts toward inventive offerings as a means of preserving their established standing. To illustrate this, in the initial month of 2022, Zoetis Inc., an American firm specializing in pharmaceuticals for companion animals and livestock, secured authorization from the US FDA for Solensia (frunevetmab injection), intended for ameliorating the discomfort associated with osteoarthritis (OA) in felines. Notably, Solensia stands out as the singular injectable monoclonal antibody therapy authorized within the United States specifically for managing the pain of feline OA. Its mechanism involves zeroing in on and deactivating nerve growth factor (NGF), which functions as a primary catalyst for pain perception in the context of osteoarthritis.
Who Are The Global Leaders Steering The Veterinary Active Pharmaceutical Ingredients Manufacturing Market Forward?
Major companies operating in the veterinary active pharmaceutical ingredients manufacturing market are Alivira Animal Health Limited, Excel Industries Limited, Ofichem Group B.V., Jiangsu Lingyun Pharmaceutical Co. Ltd., SUANFARMA S.A., NGL Fine-Chem Limited, FIS – Fabbrica Italiana Sintetici S.p.A., Lupin Limited, Aurobindo Pharma Limited, Saneca Pharmaceuticals AS, Neuland Laboratories Limited, Divi’s Laboratories Limited, Zoetis Inc., Grupo Indukern S.L., Sequent Scientific Limited, Chempro Pharma Private Limited, AMGIS Lifescience Ltd., Huvepharma AD, Vetpharma Animal Health S.L., Qilu Pharma Spain S.A., INDUKERN Chemie AG, Chemopharma S.A., Norbrook Laboratories Limited, Ceva Santé Animale S.A., Vetoquinol S.A., Virbac S.A.
Download The Full Report Here:
Which Region Is Projected To Achieve The Fastest Growth In The Veterinary Active Pharmaceutical Ingredients Manufacturing Market?
North America was the largest region in the veterinary active pharmaceutical ingredients manufacturing market in 2024. The regions covered in the veterinary active pharmaceutical ingredients manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=7942&type=smp
Browse Through More Reports Similar to the Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market 2025, By The Business Research Company
Veterinary Medical Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-medical-equipment-global-market-report
Veterinary Anesthesia Equipment Global Market Report 2025
Veterinary Patient Monitoring Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model